Daron G. Evans
Chief Financial & Business OfficerMr. Daron G. Evans M.S. M.B.A. serves as Chief Financial Officer of Rezolute, Inc. since January 23, 2024 and also serves as its Chief Business Officer. He served as Chief Executive Officer of AlloRock, Inc. He was Chief Executive Officer of Specialty Renal Products, Inc since August 24, 2020 and also served as its President and Director. Mr. Evans served as the Chief Executive Officer and President of Nephros, Inc. since April 15, 2015 until August 24, 2020 and served as its Acting Chief Financial Officer from April 15, 2015 to February 14, 2017. He served as the Chief Financial Officer of Nile Therapeutics, Inc. (formerly SMI Products, Inc.). since February 2007 and also served as its Principal Accounting Officer. He has over years of professional experience in drug development financial analysis and fiscal control. He served as the Chief Operating Officer of Nile Therapeutics, Inc. since February 13, 2007. Prior to Nile, he served as a Director of Business Assessment of Vistakon from 2006 to 2007, where he led efforts to improve R&D efficiency and speed to market. Prior to that, he served as a Director of Portfolio & Business Analytics for Scios R&D from 2004 to 2006, where he was responsible for financial controls and reporting for portfolio of six clinical stage programs and five preclinical stage programs. Mr. Evans was a co-Founder of Applied Neuronal Network Dynamics, Inc. and served as its President from 2002 to 2004. From 1995 to 2002, Mr. Evans served in various roles at consulting firms Arthur D. Little and Booz Allen & Hamilton. Mr. Evans is the author of four U. S. patents. Mr. Evans is Managing Director of PoC Capital, LLC and a Director of Zumbro Discovery, an early stage company developing a novel therapy for resistant hypertension. While at Scios, he also served as the Project Manager for the European Registration Trial of nesiritide. Mr. Evans co-founded a biotechnology diagnostic company. He served as a Management Consultant in the pharmaceutical industry with Booz Allen Hamilton. He served as the Chairman of Nephros, Inc. from January 4, 2015 to April 15, 2015 and had been its Director since November 29, 2013 2015 until August 24, 2020. Mr. Evans received his M. B.A. from The Fuqua School of Business at Duke University, his M. S. in Biomedical Engineering from a joint program at UT Southwestern Medical School and UT Arlington School of Engineering and his B. S. in Chemical Engineering from Rice University.
Positions
- Company NameRezolute, Inc.Stock CodeRZLTPositionChief Financial & Business OfficerColleagues
- NCNevan Charles ElamFounder, CEO & Acting Chairman of the Board
- BKBrian Kenneth RobertsChief Medical Officer
- SKSunil KarnawatChief Commercial Officer
- MRMichael R. DeperroSenior VP & Head of Operations
- GMGilbert M. LabrucherieIndependent Director
- WHWladimir HogenhuisIndependent Director
- NCNerissa C. KreherIndependent Director
- JMJerrold M. OlefskyMember of the Scientific Advisory Board
